Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 321.66M P/E - EPS this Y -3.60% Ern Qtrly Grth -
Income -51.92M Forward P/E -10.81 EPS next Y - 50D Avg Chg 45.00%
Sales 194.62M PEG - EPS past 5Y - 200D Avg Chg 127.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -6.00%
Recommedations 1.70 Quick Ratio 0.82 Shares Outstanding 209.37M 52W Low Chg 618.00%
Insider Own 2.47% ROA -9.31% Shares Float 189.12M Beta 0.84
Inst Own 26.30% ROE - Shares Shorted/Prior 13.40M/8.11M Price 1.73
Gross Margin 79.57% Profit Margin -26.68% Avg. Volume 2,142,154 Target Price 5.00
Oper. Margin 5.26% Earnings Date May 6 Volume 2,121,982 Change -5.98%
About Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Akebia Therapeutics, Inc. News
04/02/24 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/28/24 FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
03/28/24 Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD
03/27/24 Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
03/26/24 Akebia Awaits FDA Word On Second Crack At Vadadustat
03/17/24 Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.33
03/16/24 Akebia Therapeutics Full Year 2023 Earnings: EPS Beats Expectations
03/14/24 Akebia Therapeutics Inc (AKBA) Reports Steady Revenue and a Profitable Quarter
03/14/24 Akebia Therapeutics (AKBA) Reports Break-Even Earnings for Q4
03/14/24 Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
03/11/24 Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
01/30/24 Akebia Secures $55 Million Term Loan Financing
01/09/24 Akebia Therapeutics Announces Appointment of Nicholas Grund as Chief Commercial Officer
12/20/23 Akebia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/10/23 Akebia Therapeutics (NASDAQ:AKBA) shareholders have earned a 265% return over the last year
11/20/23 Akebia Therapeutics to Present at Piper Sandler Healthcare Conference
11/09/23 Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2023 Earnings Call Transcript
11/08/23 Q3 2023 Akebia Therapeutics Inc Earnings Call
11/08/23 Akebia Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
11/02/23 Akebia Therapeutics Announces Favorable Payment Term Modification of Loan Agreement with Pharmakon Advisors
AKBA Chatroom

User Image SwingtradingSteve Posted - 1 hour ago

$AKBA i can't stop buying this I want a juicy good avg for when the finally decide go give an update 😋

User Image Rio307 Posted - 1 hour ago

$AKBA This one is for team AKBA. Have a good weekend my friends 🍻

User Image bellingheimster Posted - 2 hours ago

$AKBA Have a great weekend everyone!

User Image ZanklinFrappa Posted - 3 hours ago

$AKBA Have a good weekend, folks. I'm gonna go drink beer and catch fish. Still holding, still long. Remaining

User Image Franco1733 Posted - 3 hours ago

$AKBA $AKBA chillin’ out maxin’ relaxin’ all cool.

User Image PlsStonks Posted - 3 hours ago

$AKBA I remember someone mentioned we had a gap around the 1.32-1.35 range, looks like it’s filled now?

User Image Christin2019 Posted - 3 hours ago

@Let_s_g0 $AKBA Of course, you know everything. What will this stock do for the next 7 - 8 months before the launch? No brain is the person that holds while the price goes down.....then they feel the pain....which is what you are doing.

User Image Ianwalsh15 Posted - 5 hours ago

$AKBA

User Image ihatemoney Posted - 5 hours ago

$AKBA lets go

User Image Benks Posted - 5 hours ago

$AKBA

User Image Elamenape2 Posted - 5 hours ago

$AKBA

User Image GeraldK75 Posted - 5 hours ago

$SBFM I choose this bankrupt co leaving $AKBA that's the dumbest thing I have done in a long time.

User Image Christin2019 Posted - 5 hours ago

$AKBA Yeppers!!!!!!!! Glad I sold my 50K at 1.93 (wish I did it when it was higher of course after the APPROVAL PR). I can now buy about 71,500 shares for the same money. That's about a 43% gain in shares. However, I think it will still go lower, just ask craptain Steve when he posted 1.20s are on the way. OH WAIT....is the CRAPTAIN still here? I'm planning to buy near the low 1s and get even more. As the CRAPTAIN said before he sold, "this is going to 5-6 on APPROVAL!!! GLTA and happy trading. BTW....when I get in on the low 1s, I'll be asking what everyone's avg price is. Don't shoot me....I just trade and don't follow CRAPTAINS!!!

User Image jd_76 Posted - 6 hours ago

$AKBA

User Image Oreo_crispy Posted - 6 hours ago

$AKBA Need to verify my blood pressure with this roller coster. But still and forever on the train

User Image Independentquest Posted - 6 hours ago

$AKBA It is the markets.

User Image Indagreen96 Posted - 6 hours ago

$AKBA who has metal?

User Image stocktrader5252 Posted - 6 hours ago

$AKBA Another week, down the f*ing drain.

User Image Scorpio1313 Posted - 6 hours ago

$AKBA It’s been a shity week for the markets !!! Enjoy the weekend bulls hasta el lunes!!!!

User Image HeavyLift Posted - 7 hours ago

$AKBA adding

User Image Bornjever Posted - 7 hours ago

$AKBA smart move to buy at these bargain prices as I paid much higher prices because these valuations are dirt cheap as these guys did over 195 million last year in revenue and to add another 100 million in revenue should be possible and they only project to lose .09 in May earnings at this point so this is absurd with these prices so I will hold .

User Image Bidzill Posted - 7 hours ago

@PlsStonks $AKBA It is so very simple yet complex at the same time. There is a large amount of self-fulfilling processes happening all the time in a chart. Check this out for an interesting read while we pass the time: https://www.investopedia.com/ask/answers/05/selffulfillingprophecy.asp#:~:text=However%2C%20those%20who,the%20predicted%20direction.

User Image Maiquyen003 Posted - 8 hours ago

$AKBA This will close green today in anticipation of earth shaking news next week! Let's go!

User Image ROCKET123 Posted - 8 hours ago

$AKBA With US approval in hand, we’re coming to a dialysis center near YOU!…hmmm💎

User Image Equalipty Posted - 8 hours ago

$AKBA Basically all of the longs are tapped out or unwilling to break the beauty of their low averages. Yep, we're going up.

User Image Maiquyen003 Posted - 8 hours ago

$AKBA well, this is my very last $2,800 buy for this stock. I dont have 1 cent left now.

User Image King_JK Posted - 8 hours ago

$AKBA This is definitely the most painful two weeks... I don't have any extra cash to spread the cost... So, I left 7 Bitcoins as a reserve... AKBA shares totaled nearly 240,000 shares. That’s it…see you on 5/13! If AKBA stock price is below 1.2$ before this... I think I will convert those 7 Bitcoins into AKBA shares...! Good luck to everyone!

User Image LucyEths Posted - 8 hours ago

$AKBA Happy Friday Akebians! Extremely heartbroken but at least no longer hanging on for dear life lol. Still here and NOT going anywhere until we hit double digits. SP has been a major disappointment, especially for long investors nearing retirement but they can’t hold a coiled spring down forever. If you must invest, this is one of the best place to park your money in an uncertain environment and crazy world we currently live in. Price doesn’t make sense but what really does at the moment? So must chaos and unrest! Let’s remember and focus on what truly matters and live every moment as if it’s our last. Have a wonderful weekend and hold on tight to your shares as they try to rip them from your hands. 🥂🍻❤️‍🩹🙏

User Image Maiquyen003 Posted - 8 hours ago

$AKBA $2.24 next week?

User Image Jabed206 Posted - 8 hours ago

$AKBA beautiful.. picking up shares and lowering my average

Analyst Ratings
HC Wainwright & Co. Buy Mar 28, 24
HC Wainwright & Co. Buy Mar 15, 24
HC Wainwright & Co. Buy Nov 17, 23
HC Wainwright & Co. Buy Sep 27, 23
HC Wainwright & Co. Buy Aug 28, 23
HC Wainwright & Co. Neutral Aug 11, 23
HC Wainwright & Co. Neutral Jun 21, 23
HC Wainwright & Co. Neutral Jun 14, 23
HC Wainwright & Co. Neutral Jun 2, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hadas Nicole R. SVP, Chief Legal Off.. SVP, Chief Legal Officer May 24 Sell 1.22 63,186 77,087 524,344 05/25/23
Dahan Michel SVP, Chief Operating.. SVP, Chief Operating Officer May 24 Sell 1.22 95,478 116,483 574,037 05/25/23
Butler John P. CEO and President CEO and President Feb 28 Sell 2.17 79,026 171,486 1,403,247 03/02/22
Burke Steven Keith SVP, Chief Medical O.. SVP, Chief Medical Officer Feb 28 Sell 2.17 15,056 32,672 217,663 03/02/22
Cotreau Violetta SVP, Chief Accountin.. SVP, Chief Accounting Officer Feb 28 Sell 2.15 3,946 8,484 29,121 03/02/22
Dahan Michel SVP, Chief Operating.. SVP, Chief Operating Officer Feb 28 Sell 2.17 21,533 46,727 297,017 03/02/22
Faulkingham Dell SVP, CCO SVP, CCO Feb 28 Sell 2.17 13,184 28,609 173,841 03/02/22
Hadas Nicole R. SVP, Chief Legal Off.. SVP, Chief Legal Officer Feb 28 Sell 2.17 21,062 45,705 304,241 03/02/22
Spellman David A SVP, CFO and Treasur.. SVP, CFO and Treasurer Feb 28 Sell 2.16 8,203 17,718 128,599 03/02/22
Faulkingham Dell CCO CCO Mar 02 Sell 3.4 6,749 22,947 128,825 03/02/21
Hadas Nicole R. SVP, Chief Legal Off.. SVP, Chief Legal Officer Mar 02 Sell 3.4 14,285 48,569 263,171 03/02/21